Skip to main content
ModernaNew customer

Messenger RNA-Based Flu Vaccine Makes Its Debut in U.S. Pharmacies: Who Can Get It?

What happened

Moderna's new mRNA flu vaccine, mFlusiva, is now available nationwide at CVS pharmacies, making CVS a key retail distributor for the product.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

The novel flu vaccine formulated with messenger RNA (mRNA) technology has officially arrived at pharmacies across the United States. Moderna's mFlusiva is now available nationwide at CVS pharmacies, while Walgreens is gearing up to receive shipments imminently. On August 6, the Food and Drug Administration (FDA) gave the green light to mFlusiva for individuals aged 50 and above, paving the way for its availability ahead of the flu season. So, who qualifies for the mFlusiva vaccination? According to the FDA's authorization, mFlusiva is intended strictly for adults aged 50 and over. The agency provided standard approval for those between 50 to 64 years and an accelerated approval for individuals 65 years or older, contingent on an additional clinical trial for this age bracket. Individuals outside this age range can opt for other approved flu vaccines suitable for their demographic. Unlike traditional flu vaccines - which typically use inactivated virus versions cultivated in eggs - mFlusiva utilizes a small piece of genetic code to train the immune system to recognize and combat the virus. "Think of it as a temporary instruction for your immune system to alert your body's natural defenses to identify the flu," explained Emlah Tubuo, an independent pharmacist based in Ohio, to NBC News. The mRNA disintegrates once its job is done, leaving no residue in the body. Immunity...

Keep reading with a free account

The rest of this article, and every signal for Moderna, is in your free account.

Extracted by Autobound

From the Signal API record
Event
New customer

What this signalsA new customer often means more work to staff, deliver and support.

Product
mFlusiva
Location
United States

More new customer signals at other companies

The full record

From the Signal API record

Topics and mentions

Product tags

  • medical
  • general technology
  • future tech

Extraction

Confidence
80%
Detected
Sep 19, 2026
signal_type
news
signal_subtype
signs_new_client

Use this data

Get every new customer signal for Moderna and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”

  2. Send it to your own tools

    The Signal API returns new customer signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/14dd9b23-d44d-e6c8-bf87-11cfff2ae4b1 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.

{
  "signal_id": "14dd9b23-d44d-e6c8-bf87-11cfff2ae4b1",
  "signal_type": "news",
  "signal_subtype": "signs_new_client",
  "detected_at": "2026-09-19T21:01:27+00:00",
  "company": {
    "name": "Moderna",
    "domain": "modernatx.com"
  },
  "data": {
    "url": "https://www.cubaheadlines.com/articles/340700",
    "title": "Messenger RNA-Based Flu Vaccine Makes Its Debut in U.S. Pharmacies: Who Can Get It? - CubaHeadlines",
    "excerpt": "The novel flu vaccine formulated with messenger RNA (mRNA) technology has officially arrived at pharmacies across the United States. Moderna's mFlusiva is now available nationwide at CVS pharmacies, while Walgreens is gearing up to receive shipments imminently. On August 6, the Food and Drug Administration (FDA) gave the green light to mFlusiva for individuals aged 50 and above, paving the way for its availability ahead of the flu season. So, who qualifies for the mFlusiva vaccination? According to the FDA's authorization, mFlusiva is intended strictly for adults aged 50 and over. The agency provided standard approval for those between 50 to 64 years and an accelerated approval for individuals 65 years or older, contingent on an additional clinical trial for this age bracket. Individuals outside this age range can opt for other approved flu vaccines suitable for their demographic. Unlike traditional flu vaccines - which typically use inactivated virus versions cultivated in eggs - mFlusiva utilizes a small piece of genetic code to train the immune system to recognize and combat the virus. \"Think of it as a temporary instruction for your immune system to alert your body’s natural defenses to identify the flu,\" explained Emlah Tubuo, an independent pharmacist based in Ohio, to NBC News. The mRNA disintegrates once its job is done, leaving no residue in the body. Immunity...",
    "product": "mFlusiva",
    "summary": "Moderna's new mRNA flu vaccine, mFlusiva, is now available nationwide at CVS pharmacies, making CVS a key retail distributor for the product.",
    "location": "United States",
    "planning": false,
    "image_url": "https://cdn0.celebritax.com/sites/default/files/styles/watermark_100/public/1789834204-primera-vacuna-contra-gripe-basada-arnm-esta-disponible-farmacias-estados-unidos.jpg",
    "confidence": 0.8,
    "product_data": {
      "name": "mFlusiva",
      "full_text": "Moderna's mFlusiva",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical",
      "general_technology",
      "future_tech"
    ],
    "published_at": "2026-09-19T21:01:27Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Moderna's mFlusiva is now available nationwide at CVS pharmacies, while Walgreens is gearing up to receive shipments imminently.",
    "related_company_name": "CVS",
    "related_company_domain": "cvs.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.